Weijin Sheng Selected Research

Apoproteins

12/2022	A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer.
12/2017	The recombinant EGFR/CD13 bi-targeted fusion protein induces apoptosis and blocks tube formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weijin Sheng Research Topics

Disease

8	Neoplasms (Cancer) 12/2022 - 04/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2018
1	Esophageal Neoplasms (Esophageal Cancer) 12/2022
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Giant Cell Carcinoma 08/2015
1	Hepatocellular Carcinoma (Hepatoma) 08/2015
1	Neoplasm Metastasis (Metastasis) 08/2015
1	Body Weight (Weight, Body) 04/2012

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2012
3	Pharmaceutical PreparationsIBA 12/2022 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 04/2012
2	C 1027IBA 12/2022 - 12/2017
2	ApoproteinsIBA 12/2022 - 12/2017
2	Immunoconjugates (Immunoconjugate)IBA 12/2022 - 01/2014
2	AlbuminsIBA 01/2020 - 01/2018
2	Recombinant ProteinsIBA 01/2020 - 01/2018
2	Immunoglobulin FragmentsIBA 12/2017 - 04/2012
1	Oxidoreductases (Dehydrogenase)IBA 12/2022
1	Inosine Monophosphate (IMP)IBA 12/2022
1	Human Serum Albumin FDA LinkGeneric 12/2022
1	Recombinant Fusion ProteinsIBA 12/2022
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	IMB5043IBA 01/2018
1	NGR peptideIBA 12/2017
1	endostar proteinIBA 08/2015
1	GelatinasesIBA 08/2015
1	Single-Chain AntibodiesIBA 04/2012

Therapy/Procedure

5	Therapeutics 12/2022 - 04/2012